Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro

Fig. 2

Acute T-AG17 administration does not alter body weight, glucose, insulin and leptin serum levels. a Body weight was analyzed every week after 17.5, 28.5, 40 and 55.5 mg/kg oral T-AG17. Changes in body weight are expressed in grams. b-d Serum biochemistry was determined using ELISA kits (insulin and leptin) as described in Methods and glucose levels measurement was determined by Glucose strips. Graphs show the normalized results of mean ± SEM for n = 6

Back to article page